• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    FMC Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    4/30/25 4:47:01 PM ET
    $FMC
    Major Chemicals
    Industrials
    Get the next $FMC alert in real time by email
    fmc-20250430
    0000037785FALSE00000377852025-04-302025-04-30

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    _______________________________________________________________________
     FORM 8-K
    _______________________________________________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15 (d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported) April 30, 2025
    __________________________________________________________________________
    FMC CORPORATION
    (Exact name of registrant as specified in its charter)
    __________________________________________________________________________ 
    Delaware1-237694-0479804
    (State or other jurisdiction of
    incorporation or organization)
    (Commission File Number)(I.R.S. Employer
    Identification No.)
    2929 Walnut StreetPhiladelphiaPennsylvania19104
    (Address of Principal Executive Offices)(Zip Code)

    Registrant’s telephone number, including area code: 215-299-6000
    __________________________________________________________________________


    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Common Stock, par value $0.10 per shareFMCNew York Stock Exchange

    Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act


    Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act.
    ☐




    ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
    On April 30, 2025, FMC Corporation issued a press release announcing the financial results for the three months ended March 31, 2025. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
    ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
    (d) Exhibits
    99.1    Press Release





    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    FMC CORPORATION
    (Registrant)
    By:/s/ ANDREW D. SANDIFER
    Andrew D. Sandifer
    Executive Vice President and Chief Financial Officer
    Date: April 30, 2025


    Get the next $FMC alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $FMC

    DatePrice TargetRatingAnalyst
    4/25/2025$49.00Neutral → Outperform
    Mizuho
    3/13/2025$51.00Buy
    Goldman
    2/14/2025$49.00Buy → Neutral
    Redburn Atlantic
    2/7/2025$66.00 → $38.00Buy → Neutral
    UBS
    2/5/2025$78.00 → $47.00Outperform → Sector Perform
    RBC Capital Mkts
    1/21/2025$65.00Equal Weight → Overweight
    Barclays
    1/14/2025$63.00 → $61.00Underperform → Neutral
    BofA Securities
    10/23/2024$67.00Neutral
    Citigroup
    More analyst ratings